Boston Pharmaceuticals
Boston - Model BOS-857 -Small Molecule Furin Inhibitor
BOS-857 is a first-in-class, inhaled, small molecule furin inhibitor with therapeutic potential in pulmonary diseases, including cystic fibrosis (CF), vascular diseases, and infectious diseases.
Most popular related searches
- Furin is one of nine members of the proprotein convertase (PC) family, which convert protein precursors into their active forms.
- Furin is responsible for processing TGF-β, ENaC, and Pseudomonas A. toxin.